Correlation Between MannKind Corp and Alnylam Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MannKind Corp and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MannKind Corp and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MannKind Corp and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on MannKind Corp and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MannKind Corp with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MannKind Corp and Alnylam Pharmaceuticals.

Diversification Opportunities for MannKind Corp and Alnylam Pharmaceuticals

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between MannKind and Alnylam is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding MannKind Corp and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and MannKind Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MannKind Corp are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of MannKind Corp i.e., MannKind Corp and Alnylam Pharmaceuticals go up and down completely randomly.

Pair Corralation between MannKind Corp and Alnylam Pharmaceuticals

Given the investment horizon of 90 days MannKind Corp is expected to generate 0.51 times more return on investment than Alnylam Pharmaceuticals. However, MannKind Corp is 1.95 times less risky than Alnylam Pharmaceuticals. It trades about -0.04 of its potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest  682.00  in MannKind Corp on August 28, 2024 and sell it today you would lose (10.00) from holding MannKind Corp or give up 1.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MannKind Corp  vs.  Alnylam Pharmaceuticals

 Performance 
       Timeline  
MannKind Corp 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in MannKind Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating forward-looking signals, MannKind Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.
Alnylam Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alnylam Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

MannKind Corp and Alnylam Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MannKind Corp and Alnylam Pharmaceuticals

The main advantage of trading using opposite MannKind Corp and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MannKind Corp position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.
The idea behind MannKind Corp and Alnylam Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.